Status:
COMPLETED
Development and Validation for Predicting Inadequate Bowel Preparation
Lead Sponsor:
Ningbo No. 1 Hospital
Conditions:
Polyethylene Glycol
Cathartics
Eligibility:
All Genders
18+ years
Brief Summary
High-quality colonoscopy is considered the gold standard for the detection and prevention of colorectal cancer, and its efficacy is predicated on optimal colon cleansing.However, about 18%-35% of pati...
Eligibility Criteria
Inclusion
- patients undergoing colonoscopy.
- patients older than 18 years.
Exclusion
- Emergency colonoscopy.
- Have a serious medical condition, such as heart failure, acute liver failure, severe kidney disease (dialysis or predialysis patients) or New York heart association class iii-iv.
- Pregnant or breastfeeding.
- No bowel preparation or poor compliance (no bowel preparation as instructed or laxatives \< 90% of prescribed dose).
- Refuse to sign informed consent.
- The patient was rescheduled after the previous colonoscopy due to insufficient bowel preparation.
- Temporarily change to colonoscopy for other reasons.
- Incomplete colonoscopy due to insufficient parenteral preparation.
- Lack of complete data.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
1644 Patients enrolled
Trial Details
Trial ID
NCT04290715
Start Date
January 1 2020
End Date
April 30 2021
Last Update
August 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ningbo First Hospital
Ningbo, Zhejiang, China, 315010